Image Results

Seattle Genetics Pages on BioPortfolio:

Biotechnology News Seattle Genetics Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio Biotechnology BioNews : live article
Seattle Genetics Reports Second Quarter 2007 Financial Results and Highlights ... As of June 30, 2007, Seattle Genetics had $132.2 million in cash and ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Biotechnology News Genetics Search
19 Nov 2009 ... Seattle Genetics Bearish Technical Alert - Trend Down 14.6% More .upCom2 UPCOMING EVENTS Learn new strategies, how to trade in this market, ...
http://www.bioportfolio.co.uk/Genetics-news.htm...

Biotechnology News Lymphoma Large-Cell Follicular Search
Seattle Genetics Announces Discontinuation Of Dacetuzumab Phase IIb Diffuse Large B-Cell Lymphoma Clinical Tri Seattle Genetics, Inc. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Biotechnology News pancreatic cancer Search
Seattle Genetics Initiates Phase I Clinical Trial of Antibody-Drug ... (Business Wire) Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that it has ...
http://www.bioportfolio.co.uk/pancreatic%20cancer-news.htm...

Biotechnology News Targeted Genetics Search
(SGEN) Seattle Genetics (NASDAQ:SGEN) is trading 2.3% lower (down $0.22 to $9.50 ) today on volume of 147384 shares. The stock has traded within a 52-week ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio's NASDAQ Top Biotech Companies News Feed
PROTEIN DESIGN LABS INC · REGENERATION TECHNOLOGIES · REGENERON PHARMACEUTICALS · REPLIGEN CORPORATION · SANGAMO BIOSCIENCES INC · SEATTLE GENETICS INC /WA ...
http://www.bioportfolio.co.uk/news/nasdaq_top_bio150_1.shtml...

BioPortfolio's Lymphoma News and Headlines
Seattle Genetics Initiates Phase I Clinical Trial Of Antibody-Drug Conjugate SGN -75 ... Seattle Genetics Initiates Phase I Clinical Trial of Antibody-Drug ...
http://www.bioportfolio.co.uk/Health_News/Lymphoma.shtml...

BioPortfolio - Seattle Genetics
Seattle Genetics - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/9307-Seattle_Geneti...

Biotechnology News CARBOPLATIN Search
Seattle Genetics discontinues Phase IIb lymphoma trial. Seattle Genetics, a biotechnology company, has discontinued the SeaGen Mariner clinical trial based
...
http://www.bioportfolio.co.uk/CARBOPLATIN-news.htm...

Results from other life science and pharmaceutical sites:

SGEN: Profile for Seattle Genetics, Inc. - Yahoo! Finance
See the company profile for Seattle Genetics, Inc. (SGEN) including business summary, industry/sector information, number of employees, business summary, ...
http://biz.yahoo.com/p/s/sgen.html...

Seattle Genetics, Inc. - Google Finance
Get the latest on Seattle Genetics, Inc. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=NASDAQ:SGEN...

BioSpace - Seattle Genetics, Inc. News, Search Jobs, Events
At Seattle Genetics, we are committed to developing innovative antibody-based therapies that improve clinical outcomes for patients with cancer and ...
http://www.biospace.com/company_profile.aspx?CompanyId=3510...

Seattle Genetics Inc. - Company Profile - BioCentury
Seattle Genetics' detailed financials; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma
industry ...
http://www.biocentury.com/companies/Seattle_Genetics_Inc?utm...

...

Targeted Genetics Corporation
Targeted Genetics at Rodman & Renshaw Annual Global Healthcare Conference ... 10 /1/2009, Nasdaq Grants Targeted Genetics Corporation an Extension to Regain ...
http://www.targen.com/...

Seattle Genetics Highlights Pipeline Progress and Reports Third ...
22 Oct 2009 ... BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN - News) today reported financial results for the third quarter and nine ...
http://biz.yahoo.com/bw/091022/20091022006387.html?.v=1...

News: Seattle Genetics Shutters B-Cell Lymphoma Program.
5 Oct 2009 ... Dacetuzumab is a humanized mAb that targets the CD40 antigen, which is expressed on most B lineage hematologic malignancies as well as some ...
http://www.genengnews.com/news/bnitem.aspx?name=64625433...

Seattle Genetics to Present at Upcoming Investor Conferences ...
27 Oct 2009 ... BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN - News) announced today that management will present at two upcoming ...
http://biz.yahoo.com/bw/091027/20091027006241.html?.v=1...

Seattle Genetics, Inc. Stops Mid-Stage Cancer Trial - News, Search ...
6 Oct 2009 ... (BUSINESS WIRE)--Seattle Genetics, Inc. announced today that it has discontinued the SeaGen MARINER clinical trial based on a determination ...
http://www.biospace.com/news_story.aspx?NewsEntityId=157986...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.